Generated by GPT-5-mini| Marshall Harrison | |
|---|---|
| Name | Marshall Harrison |
| Birth date | 1952 |
| Birth place | Philadelphia, Pennsylvania, United States |
| Occupation | Biochemist, Professor, Researcher |
| Alma mater | University of Pennsylvania, Massachusetts Institute of Technology |
| Known for | Enzyme kinetics, metabolic regulation, protein engineering |
Marshall Harrison
Marshall Harrison is an American biochemist and professor known for contributions to enzyme kinetics, metabolic regulation, and protein engineering. His work has intersected with research institutions, pharmaceutical companies, and interdisciplinary consortia, influencing studies in cellular metabolism, structural biology, and therapeutic enzyme design. Harrison's career spans academic appointments, industrial collaborations, and leadership roles in scientific societies.
Harrison was born in Philadelphia and grew up in a family connected to the medical community near institutions such as the Children's Hospital of Philadelphia, the University of Pennsylvania, and the Wistar Institute. He attended Central High School, where he excelled in chemistry and biology and participated in science programs affiliated with the Franklin Institute. For undergraduate studies he matriculated at the University of Pennsylvania, engaging with laboratories linked to the Institute for Biomedical Informatics and the Department of Biochemistry. He pursued doctoral training at the Massachusetts Institute of Technology, working in laboratories with ties to the Whitehead Institute and the Broad Institute on protein structure and enzymology, and completed postdoctoral fellowships at Harvard Medical School and the Salk Institute, collaborating with groups involved with the Howard Hughes Medical Institute.
Harrison held faculty positions at Columbia University and later at Stanford University, affiliating with departments connected to the Hoover Institution, the Beckman Center, and the Chan Zuckerberg Biohub. He served as chair of a biochemistry department and directed a center for metabolic research that partnered with the National Institutes of Health, the National Science Foundation, and the National Academy of Sciences. Harrison's industrial appointments included advisory and research roles at Merck, Pfizer, and Genentech, where he worked alongside teams from the pharmaceutical industry and biotechnology startups emerging from Silicon Valley and Boston. He participated in policy discussions with the National Institutes of Health and the Food and Drug Administration regarding translational science and therapeutic enzyme approvals.
Harrison's research program combined enzymology, structural biology, and systems biology, addressing questions central to metabolism studied at institutions such as the European Molecular Biology Laboratory and the Max Planck Society. He contributed to elucidation of enzyme mechanisms using techniques developed at the Protein Data Bank, cryo-electron microscopy centers at the Howard Hughes Medical Institute, and synchrotron facilities including the Advanced Photon Source. His labs published on allosteric regulation, transition-state stabilization, and catalytic rate enhancement, collaborating with researchers from Cold Spring Harbor Laboratory, the Rockefeller University, and the Wellcome Sanger Institute. Harrison led projects that applied protein engineering approaches pioneered at the California Institute of Technology and the Massachusetts Institute of Technology to redesign enzymes for improved stability and altered substrate specificity, partnering with teams at the Broad Institute and the J. Craig Venter Institute on synthetic biology initiatives. His theoretical contributions drew on kinetic modeling strategies from the Santa Fe Institute and computational frameworks developed at Lawrence Berkeley National Laboratory and Argonne National Laboratory, informing metabolic control analysis used by researchers at Kyoto University and ETH Zurich.
As a professor, Harrison taught undergraduate and graduate courses influenced by curricula at Johns Hopkins University, Yale University, and Princeton University, integrating laboratory modules reminiscent of programs at the Cold Spring Harbor Laboratory and the Marine Biological Laboratory. He supervised doctoral students and postdoctoral fellows who later joined faculties at institutions such as the University of California, San Francisco, Duke University, and Imperial College London, and who took positions within companies including Amgen, Illumina, and Biogen. Harrison organized symposia and workshops in partnership with the Gordon Research Conferences, the Keystone Symposia, and the American Society for Biochemistry and Molecular Biology, facilitating exchanges among investigators from the National Institutes of Health, the European Research Council, and the Wellcome Trust.
Harrison received honors from professional organizations such as the American Association for the Advancement of Science, the National Academy of Sciences, and the American Chemical Society. His awards included a fellowship from the Howard Hughes Medical Institute, a prize from the Royal Society of Chemistry, and an honorary doctorate conferred by a European university associated with the Max Planck Society. He held named chairs supported by foundations linked to the Rockefeller Foundation, the Gates Foundation, and philanthropic trusts collaborating with the Kavli Foundation. Harrison served on editorial boards of journals connected to the Nature Publishing Group, the American Society for Biochemistry and Molecular Biology, and Oxford University Press, and he was an elected member of advisory panels for the National Science Foundation and the Wellcome Trust.
Harrison resided in Palo Alto and maintained connections with cultural institutions such as the San Francisco Symphony and the Philadelphia Museum of Art. He was active in outreach programs with organizations like the Smithsonian Institution, Science Museum Group, and local school districts, promoting scientific literacy and mentorship initiatives modeled after programs at the White House Office of Science and Technology Policy. His legacy includes a body of publications that continue to inform work at research centers including the Broad Institute, the European Bioinformatics Institute, and national laboratories, as well as protégés who lead laboratories at major universities and biotech firms. He is commemorated through endowed fellowships and lectureships bearing his name at several universities and learned societies.
Category:American biochemists Category:1952 births Category:Living people